PARALLEL SESSION 11 - PHARMACOLOGY 1
Tracks
ZAGREB
| Wednesday, October 22, 2025 |
| 4:00 PM - 6:00 PM |
Overview
Drug therapy in special neonatal diseases
Details
Moderators: Sezin Unal, Turkey and TBA
16:00 - 16:30
Individualized drug therapy in neonatal asphyxia
Anne Smits, Belgium
16:30 - 17:00
Pharmacotherapy in necrotising enterocolitis. What is new?
Genny RaffaeIi, Italy
17.00 – 17.15 10
The Role of Artificial Intelligence in Optimizing Pharmacological Treatment in Neonatology and Pediatrics: A Scoping Review. Giacomo Cavallaro (Italy)
17.15 – 17.30 597
Impact of Discontinuing Open-Label Doxapram on Parental Consent and Enrollment Rates in the DOXA Trial Kelly Storm (Netherlands)
17.30 – 17.45 197
Systematic review and model selection criteria to guide model-informed precision dosing of vancomycin in neonates and children Zoe Vander Elst (Belgium)
17.45 - 18.00 407
From data to dose: Solving the neonatal dosing gaps with NeoDose Lianne van Bussel (Netherlands)
16:00 - 16:30
Individualized drug therapy in neonatal asphyxia
Anne Smits, Belgium
16:30 - 17:00
Pharmacotherapy in necrotising enterocolitis. What is new?
Genny RaffaeIi, Italy
17.00 – 17.15 10
The Role of Artificial Intelligence in Optimizing Pharmacological Treatment in Neonatology and Pediatrics: A Scoping Review. Giacomo Cavallaro (Italy)
17.15 – 17.30 597
Impact of Discontinuing Open-Label Doxapram on Parental Consent and Enrollment Rates in the DOXA Trial Kelly Storm (Netherlands)
17.30 – 17.45 197
Systematic review and model selection criteria to guide model-informed precision dosing of vancomycin in neonates and children Zoe Vander Elst (Belgium)
17.45 - 18.00 407
From data to dose: Solving the neonatal dosing gaps with NeoDose Lianne van Bussel (Netherlands)
Speaker
Dr. Giacomo Cavallaro
Doctor
Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
The Role of Artificial Intelligence in Optimizing Pharmacological Treatment in Neonatology and Pediatrics: A Scoping Review.
Ms. Kelly Storm
Researcher
Erasmus Mc - Sophia Children's Hospital
Impact of Discontinuing Open-Label Doxapram on Parental Consent and Enrollment Rates in the DOXA Trial
Ms. Lianne van Bussel
Researcher
Radboud University Medical Center (Radboudumc)
From data to dose: Solving the neonatal dosing gaps with NeoDose
Dr. Zoe Vander Elst
Resident
UZ Leuven/KU Leuven
Systematic review and model selection criteria to guide model-informed precision dosing of vancomycin in neonates and children
The Organising Secretariat
Any questions or comments please contact us at info@jenscongress.eu
Follow us to stay updated!
